Name : Ashish Kumar(48Y/M)

Date : 18 Dec 2024

Test Asked : Executive Checkup

Report Status: Complete Report

PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF
HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
TEST ASKED : EXECUTIVE CHECKUP HARYANA 132103

Report Availability Summary

Note: Please refer to the table below for status of your tests.

16 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

EXECUTIVE CHECKUP Ready

CYSTATIN C Ready

FRUCTOSAMINE Ready

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready

Lipoprotein (a) [Lp(a)] Ready

SERUM COPPER Ready

SERUM ZINC Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready

VITAMIN D TOTAL AND B12 COMBO Ready

APOLIPROTEIN RATIO Ready

BLOOD KETONE (D3HB) Ready

PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT HARYANA
TEST ASKED : EXECUTIVE CHECKUP 132103

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) 5.14 mg/L <3
TRIG / HDL RATIO 4.47 Ratio < 3.12
COMPLETE HEMOGRAM
HEMATOCRIT(PCV) 50.7 % 40.0-50.0
LYMPHOCYTE 42.7 % 20-40
LYMPHOCYTES - ABSOLUTE COUNT 3.23 X 10³ / µL 1.0-3.0
MEAN [Link](MCHC) 29.4 g/dL 31.5-34.5
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.2 pq 27.0-32.0
MEAN CORPUSCULAR VOLUME(MCV) 82.4 fL 83.0-101.0
MEAN PLATELET VOLUME(MPV) 13.3 fL 6.5-12
PLATELET DISTRIBUTION WIDTH(PDW) 19.2 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 50.8 % 19.7-42.4
TOTAL RBC 6.15 X 10^6/µL 4.5-5.5
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 226 mg/dL 90-120
FRUCTOSAMINE 311.04 µmol/L <=286
HbA1c 9.5 % < 5.7
LIPID
HDL / LDL RATIO 0.26 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 37 mg/dL 40-60
LDL / HDL RATIO 3.8 Ratio 1.5-3.5
LDL CHOLESTEROL - DIRECT 140 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO 5.2 Ratio 3-5
TRIGLYCERIDES 165 mg/dL < 150
LIVER
ALANINE TRANSAMINASE (SGPT) 59.09 U/L < 45
ASPARTATE AMINOTRANSFERASE (SGOT ) 42.36 U/L < 35
RENAL
BLOOD UREA NITROGEN (BUN) 7.9 mg/dL 7.94 - 20.07
CREATININE - SERUM 0.65 mg/dL 0.72-1.18
CYSTATIN C 1.13 mg/L < = 1.03

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT HARYANA
TEST ASKED : EXECUTIVE CHECKUP 132103

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
UREA (CALCULATED) 16.91 mg/dL Adult : 17-43
VITAMINS
25-OH VITAMIN D (TOTAL) 20.54 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

CYSTATIN C IMMUNOTURBIDIMETRY 1.13 mg/L
Bio. Ref. Interval. :-

<= 60 years: <= 1.03 mg/L

> 60 years : < 1.50 mg/L

Clinical significance

Cystatin c, is a small 13-kda protein and is a member of the cysteine proteinase inhibitor family, it is produced at a constant rate
by all nucleated cells. Due to its small size it is freely filtered by the glomerulus and is not secreted but is fully reabsorbed and
broken down by the renal tubules. This means that the primary determinate of blood Cystatin c levels is the rate at which it is
filtered at the glomerulus making it an excellent gfr marker. Cystatin c is also a marker of inflammation and like many other
markers of inflammation; its serum concentration may be higher in patients with decreased renal clearance. There is mounting
evidence, however, that Cystatin c may be a predictor of adverse outcomes independent of renal function with its higher
sensitivity to detect a reduced GFR than Creatinine determination, also in the so-called “Creatinine-blind” range. Thus, Cystatin c
is suggested to be a better marker for GFR than the ubiquitous serum Creatinine.

Reference

1. Barrett aj, Davies me, Grubb a. the place of human gamma-trace (Cystatin c) among the cysteine proteinase inhibitors. Biochem
biophys res common 1984; 120: 631-6.

2. Grubb a. diagnostic value of analysis of Cystatin c and protein HC in biological fluids. Clin Nephrol 1992; 38: S20-7.

Please correlate with clinical conditions.

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Dr Nikita MD(Path)
Labcode : 1812096809/PP004
Barcode : CZ898784 Page : 1 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
: SELF
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) C.L.I.A 20.54 ng/mL

Bio. Ref. Interval. :
DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml
SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml

Clinical Significance:

Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building
bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome. Increase in
vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.

Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.

Method : Fully Automated Chemi Luminescent Immuno Assay

VITAMIN B-12 C.L.I.A 216 pg/mL
Bio. Ref. Interval. :

Normal : 211 - 911 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

Kit Validation reference:

Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby; 1987:569–73.

Method : COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01

Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)
Barcode : CZ898784
Page : 2 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
: SELF
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 132 mg/dL

Bio. Ref. Interval. :
Male : 86 - 152
Female : 94 - 162

Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 102 mg/dL
Bio. Ref. Interval. :
Male : 56 - 145
Female : 53 - 138

Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.8 Ratio
Bio. Ref. Interval. :
Male : 0.40 - 1.26
Female : 0.38 - 1.14

Method : Derived from serum Apo A1 and Apo B values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01

Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)
Barcode : CZ898784
Page : 3 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 5.14 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

[Link] management of laboratory date in medical practice 2003-3004, 207(2003).
[Link] : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Dr Nikita MD(Path)
Labcode : 1812096809/PP004
Barcode : CZ898784 Page : 4 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
: SELF
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

FRUCTOSAMINE PHOTOMETRY 311.04 µmol/L

Bio. Ref. Interval. :

Normal < 286 µmol/L

Clinical Significance:

Fructosamine assay is useful in monitoring the degree of glycemia over short-to-intermediate time frames (1-3 weeks) concentration greater than
the established normal range is an indication of prolonged hyperglycemia of 1-3 weeks or longer. The higher fructosamine value, poorer is the
degree of glycemia control.

Specifications:

Precision %CV : Intra assay %CV- 3.2% , Inter assay %CV-4.0%, Sensitivity:- 290 umol/L

Kit Validation Reference:

Howey JEA, Browning MCK, Fraser CG. Assay of serum fructosamine that minimizes standardization and matrix problems: Use to assess
components of biological va-riation. Clin Chem 1987; 33: 269- 272.

Method : NITROBLUE TETRAZOLIUM ASSAY (NBT)

BLOOD KETONE (D3HB) PHOTOMETRY 0.42 mg/dL
Bio. Ref. Interval. :
0.21-2.81 mg/dL

Clinical Significance:
Three types of ketones can be produced in body D-3- Hydroxybutyrate, Acetoacetate and Acetone. D-3- Hydroxybutyrate accounts for
approximately 75% of the ketone bodies. During periods of ketosis, D-3- Hydroxybutyrate increases more than the other two. It has been shown
to be a better index of ketoacidosis. In diabetics, D-3- Hydroxybutyrate is needed for the assessment of the severity of diabetic coma and to
calculate insulin requirements.

Speficcation:
Precision: Intra assay (%CV): 4.53, Inter assay (%CV): 2.9, Sensitivity: 10.41 mg/dL.

Kit validation references:

Mcmurray, C.H., Blanchflower, W.J., Rice, D.A., ClinChem., 1984;30:No.3.

Method : ENZYMATIC (KINETIC)

Please correlate with clinical conditions.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01

Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)
Barcode : CZ898784
Page : 5 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY <2 mg/dL
Bio. Ref. Interval. :-

Adults : < 30.0 mg/dl

Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.

Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %

Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Please correlate with clinical conditions.

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Dr Nikita MD(Path)
Labcode : 1812096809/PP004
Barcode : CZ898784 Page : 6 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

SERUM COPPER PHOTOMETRY 105.9 µg/dL
Bio. Ref. Interval. :-

Male : 63.5 - 150

Female : 80 - 155

Clinical significance:
Copper is an important trace element and a component of numerous enzymes and proteins involved in energy production,
connective tissue formation, melanin synthesis, iron metabolism, development of central nervous system, angiogenesis as well as
an antioxidant. Deficiency can cause- Malnourishment, cardiovascular disease, anemia & neuropathy, toxicity may be manifested
as acute renal failure, gastroenteritis & chronic liver disease.

Specifications:
Precision: Intra assay (%CV): 1.17, Inter assay (%CV): 2.32.

Kit validation references:

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 337-8

Please correlate with clinical conditions.

Method:- 3,5-DIBR-PAESA

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Dr Nikita MD(Path)
Labcode : 1812096809/PP004
Barcode : CZ898784 Page : 7 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

SERUM ZINC PHOTOMETRY 72.3 µg/dL
Bio. Ref. Interval. :-

52 - 286

Clinical Significance:
Zinc is one of the essential trace elements in the body. Its metalloenzymes play a key rple in protein and nucleic acid synthesis,
gene expression, wound healing, as an antioxidant, etc. Deficiency can cause- Poor wound healing, gastroenteritis, impaired
spermatogenesis, Alzheimer’s disease, etc. Toxicity may be manifested as pancreatitis, gastric ulcer, anemia, pulmonary fibrosis.

Specifications:
Precision: Intra assay (%CV): 2.02, Inter assay (%CV): 2.22.

Kit Validation References:

Thomas L. Clinical Laboratory Diagnostics. 1st ed. Frankfurt: TH-Books Verlagsgesellschaft; 1998. p. 347-9

Please correlate with clinical conditions.

Method:- NITRO - PAPS

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Dr Nikita MD(Path)
Labcode : 1812096809/PP004
Barcode : CZ898784 Page : 8 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
: SELF
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 114.05 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170

Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 311.67 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 36.59 %
Bio. Ref. Interval. :
13 - 45

Method : Derived from IRON and TIBC values

[Link]-BINDING CAPACITY(UIBC) PHOTOMETRY 197.62 µg/dL
Bio. Ref. Interval. :
162 - 368

Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01

Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)
Barcode : CZ898784
Page : 9 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No 436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT HARYANA
: SELF
132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 193 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 37 mg/dL 40-60
TRIGLYCERIDES PHOTOMETRY 165 mg/dL < 150
LDL CHOLESTEROL - DIRECT PHOTOMETRY 140 mg/dL < 100
TC/ HDL CHOLESTEROL RATIO CALCULATED 5.2 Ratio 3-5
TRIG / HDL RATIO CALCULATED 4.47 Ratio < 3.12
LDL / HDL RATIO CALCULATED 3.8 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.26 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 155.96 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 32.95 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
TRIG - Enzymatic, End Point
LDL - Direct Measure
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)

Barcode : CZ898784 Page : 10 of 17

PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No 436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT HARYANA
: SELF
132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 91.31 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.88 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.17 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.71 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 51.1 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 42.36 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 59.09 U/L < 45
SGOT / SGPT RATIO CALCULATED 0.72 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.03 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.84 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.19 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.2 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)

Barcode : CZ898784 Page : 11 of 17

PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No 436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT HARYANA
: SELF
132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.9 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.65 mg/dL 0.72-1.18
BUN / [Link] RATIO CALCULATED 12.15 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 16.91 mg/dL Adult : 17-43
UREA / [Link] RATIO CALCULATED 26.01 Ratio < 52
URIC ACID PHOTOMETRY 5.01 mg/dL 4.2 - 7.3
CALCIUM PHOTOMETRY 9.06 mg/dL 8.8-10.6
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and [Link] values.
URIC - Uricase / Peroxidase Method
CALC - Arsenazo III Method, End Point.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)

Barcode : CZ898784 Page : 12 of 17

 PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

HOUSE NO 39 SECTOR 12 HUDDA PANIPAT HARYANA
REF. BY : SELF
132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 135 ng/dL 60-200
TOTAL THYROXINE (T4) C.L.I.A 11.4 µg/dL 4.5-12
TSH - ULTRASENSITIVE C.L.I.A 3.719 µIU/mL 0.55-4.78

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3 - Competitive Chemi Luminescent Immuno Assay

T4 - Competitive Chemi Luminescent Immuno Assay
USTSH - Third Generation Ultrasensitive Chemi Luminescent Immuno Assay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Labcode : 1812096809/PP004 Dr Nikita MD(Path)
Barcode : CZ898784 Page : 13 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 115 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:01
Report Released on (RRT) : 18 Dec 2024 21:42
Sample Type : SERUM
Dr Nikita MD(Path)
Labcode : 1812096809/PP004
Barcode : CZ898784 Page : 14 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
: SELF
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 9.5 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 226 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:03

Report Released on (RRT) : 18 Dec 2024 22:52
Sample Type : EDTA Whole Blood
Labcode : 1812096890/PP004 Dr Nikita MD(Path)
Barcode : DB070581
Page : 15 of 17
PROCESSED AT :
Thyrocare
Plot No 436C,3rd Floor,
Industrial Plot No
436,Sector-82,JLPL,
SAS Nagar,Mohali,Punjab.

NAME : ASHISH KUMAR(48Y/M) HOME COLLECTION :

REF. BY : SELF HOUSE NO 39 SECTOR 12 HUDDA PANIPAT
HARYANA 132103
TEST ASKED : EXECUTIVE CHECKUP

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 14.9 g/dL 13.0-17.0
Hematocrit (PCV) CPH Detection 50.7 % 40.0-50.0
Total RBC HF & EI 6.15 X 10^6/µL 4.5-5.5
Mean Corpuscular Volume (MCV) Calculated 82.4 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 24.2 pq 27.0-32.0
Mean [Link]. Conc (MCHC) Calculated 29.4 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 39.7 fL 39-46
Red Cell Distribution Width (RDW - CV) Calculated 13.4 % 11.6-14
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 179.5 - *Refer Note below
MENTZER INDEX Calculated 13.4 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.56 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 45.7 % 40-80
Lymphocytes Percentage Flow Cytometry 42.7 % 20-40
Monocytes Percentage Flow Cytometry 7 % 2-10
Eosinophils Percentage Flow Cytometry 3.4 % 1-6
Basophils Percentage Flow Cytometry 0.9 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0-0.5
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 3.45 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 3.23 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.53 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.07 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.26 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 194 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 13.3 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 19.2 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 50.8 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.26 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with microcytes & ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)
~~ End of report ~~

Sample Collected on (SCT) : 18 Dec 2024 06:55

Sample Received on (SRT) : 18 Dec 2024 20:03
Report Released on (RRT) : 18 Dec 2024 22:52
Sample Type : EDTA Whole Blood
Labcode : 1812096890/PP004 Dr Nikita MD(Path)
Barcode : DB070581 Page : 16 of 17
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- [Link]

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v [Link] - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at customersupport@[Link]
or call us on 022-3090 0000

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 17 of 17